1-5 of 5
Matthew B. Soellner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A009: Integrative drug screening and multi-omic characterization of patient-derived bladder cancer organoids reveals novel molecular correlates of chemotherapy response

Nathan M. Merrill, Samuel D. Kaffenberger, Liwei Bao, Nathalie Vandecan, Laura E. Goo, Athena Apfel, Xu Cheng, Zhaoping Qin, Chia-Jen Liu, Armand Bankhead, Yin Wang, Varun Kathawate, Lila Tudrick, Habib Serhan, Zackariah Farah, Chad Ellimoottil, Khaled S. Hafez, Lindsey A. Herrel, Jeffrey S. Montgomery, Todd M. Morgan, Simpa S. Salami, Alon Z. Weizer, Peter J. Ulintz, Mark L. Day, Matthew B. Soellner, Phillip L. Palmbos, Sofia D. Merajver, Aaron M. Udager
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (10_Supplement): A009.
https://doi.org/10.1158/1557-3265.BLADDER24-A009
Published: 17 May 2024
View article titled, Abstract A009: Integrative drug screening and multi-omic characterization of patient-derived bladder cancer organoids reveals novel molecular correlates of chemotherapy response
Journal Articles

Abstract B020: Development of novel Src-targeting strategies to block bladder cancer invasive progression

Nicole A. Jerome, Yin Wang, Marian L. Henderson, Luke Broses, Kathleen C. Day, Mark L. Day, Matthew B. Soellner, Phillip L. Palmbos
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (10_Supplement): B020.
https://doi.org/10.1158/1557-3265.BLADDER24-B020
Published: 17 May 2024
View article titled, Abstract B020: Development of novel Src-targeting strategies to block bladder cancer invasive progression
Journal Articles

Abstract 38: Molecular determinants of drug response in TNBC cell lines

Nathan M. Merrill, Eric J. Lachacz, Nathalie M. Vandecan, Peter J. Ulintz, Li Wei Bao, John P. Lloyd, Aki Morikawa, Sofia D. Merajver, Matthew B. Soellner
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (12_Supplement_1): 38.
https://doi.org/10.1158/1557-3265.ADVPRECMED20-38
Published: 15 June 2020
View article titled, Abstract 38: Molecular determinants of drug response in TNBC cell lines
Journal Articles

Retraction: UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer

Rabia A. Gilani, Sameer Phadke, Li Wei Bao, Eric J. Lachacz, Michele L. Dziubinski, Kristoffer R. Brandvold, Michael E. Steffey, Frank E. Kwarcinski, Carrie R. Graveel, Kelley M. Kidwell, Sofia D. Merajver, Matthew B. Soellner
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (7): 1777.
https://doi.org/10.1158/1078-0432.CCR-20-0653
Published: 01 April 2020
View article titled, Retraction: UM-164: A Potent c-Src/p38 Kinase Inhibitor with <em>In Vivo</em> Activity against Triple-Negative Breast Cancer
Open the PDF for Retraction: UM-164: A Potent c-Src/p38 Kinase Inhibitor with <em>In Vivo</em> Activity against Triple-Negative Breast Cancer in another window
Journal Articles

UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer

Rabia A. Gilani, Sameer Phadke, Li Wei Bao, Eric J. Lachacz, Michele L. Dziubinski, Kristoffer R. Brandvold, Michael E. Steffey, Frank E. Kwarcinski, Carrie R. Graveel, Kelley M. Kidwell, Sofia D. Merajver, Matthew B. Soellner
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (20): 5087–5096.
https://doi.org/10.1158/1078-0432.CCR-15-2158
Published: 13 October 2016
View article titled, UM-164: A Potent c-Src/p38 Kinase Inhibitor with <em>In Vivo</em> Activity against Triple-Negative Breast Cancer
Open the PDF for UM-164: A Potent c-Src/p38 Kinase Inhibitor with <em>In Vivo</em> Activity against Triple-Negative Breast Cancer in another window
Includes: Supplementary data